Close Menu

NEW YORK (GenomeWeb) – Curetis reported today that its first quarter revenues rose 161 percent on continued demand for its Unyvero molecular diagnostic system.

For the three-month period ended March 31, Curetis' revenues increased to €347,166 ($388,393) from €132,810 a year earlier.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.